Proposed Data Collections Submitted for Public Comment and Recommendations, 15524-15525 [E8-5859]

Download as PDF 15524 Federal Register / Vol. 73, No. 57 / Monday, March 24, 2008 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Vaccine Safety Working Group Department of Health and Human Services, Office of the Secretary. ACTION: Notice. mstockstill on PROD1PC66 with NOTICES AGENCY: SUMMARY: The Department of Health and Human Services (DHHS) is hereby giving notice that the National Vaccine Program Office (NVPO) will convene a meeting of NVAC’s Vaccine Safety Working Group. The meeting is open to the public. DATES: The meeting will be held on April 11, 2008, from 9 a.m. to 5 p.m. ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey Building, Room 705A; 200 Independence Avenue, SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Daniel Salmon, Vaccine Safety Specialist, National Vaccine Program Office, Department of Health and Human Services, Room 443-H Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201; (202) 260–1587 or daniel.salmon@hhs.gov. SUPPLEMENTARY INFORMATION: NVPO has responsibility for coordinating and ensuring collaboration among the many Federal agencies involved in vaccine and immunization activities. The NVPO provides leadership and coordination among Federal agencies, as they work together to carry out the goals of the National Vaccine Plan. The National Vaccine Plan provides a framework, including goals, objectives, and strategies, for pursuing the prevention of infectious diseases through immunizations. NVPO periodically convenes groups to address specific issues and topics that impact vaccine and immunization. The Vaccine Safety Working Group has been established to (1) undertake and coordinate a scientific review of the draft Immunization Safety Office (Centers for Disease Control and Prevention) research agenda, and (2) review the current vaccine safety system. Following the advice of the Institute of Medicine in its report ‘‘Vaccine Safety Research, Data Access and Public Trust’’ (February 17, 2005), this meeting of the Working Group is open to the public, noting that pubic attendance is limited to space available. Individuals must provide a photo ID for entry into the Humphrey Building. Individuals VerDate Aug<31>2005 16:33 Mar 21, 2008 Jkt 214001 who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person. Members of the public will have the opportunity to provide comments at the meeting. Public comment will be limited to five minutes per speaker. Any members of the public who wish to have printed material distributed to meeting participants should submit materials to the NVPO staff person designated as the contact for additional information. All materials should be submitted to the designated point of contact no later than close of business April 9, 2008. Preregistration is required for both public attendance and comment. Any individual who wishes to attend the meeting and/or participate in the public comment session should contact the designated staff member, Daniel Salmon, by e-mail daniel.salmon@hhs.gov or call 202– 690–5566. Dated: March 18, 2008. Bruce Gellin, Director, National Vaccine Program Office. [FR Doc. E8–5892 Filed 3–21–08; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–08–08AU] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 and send comments to Maryam Daneshvar, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Assessing Problem Areas in Referrals for Chronic Hematologic Malignancies and Developing Interventions to Address Them—New—Division of Cancer Prevention and Control (DCPC), National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description: One of the six aims of the Insitute of Medicine’s Crossing the Quality Chasm report is to improve the timeliness of care for patients. Data from Europe and Canada, as well as single-site studies in the United States, allude to a problem of timely referral and diagnosis for patients with cancer. Despite the advent of new diagnostics and therapeutics for patients with chronic hematological malignancies, the size and scope of a potential problem regarding their referral from primary care providers to specialists is not well-defined in the current literature. CDC proposes to conduct a one-time study to collect qualitative and quantitative information on optimal and sub-optimal referral patterns for patients with confirmed or suspected chronic hematologic malignancies. Information will be collected to identify specific factors related to delays in diagnosis and/or referral to appropriate medical specialists. Information will be collected through in-depth interviews with hematologic cancer patients, in-depth interviews and focus groups with primary care providers, interviews with specialists in hematology and oncology in Texas, and a one-time postal survey to a sample of primary care providers (physicians and advance practice nurses) in Massachusetts. The ultimate goal is to develop tools that will improve the awareness, diagnosis, and referral of persons with chronic hematological cancers by primary care providers. There are no costs to respondents other than their time. E:\FR\FM\24MRN1.SGM 24MRN1 15525 Federal Register / Vol. 73, No. 57 / Monday, March 24, 2008 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Type of respondents Community tologists. Oncologists/Hema- Patients ............................................. Primary Care Providers .................... Total .......................................... ......................................................... BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–08–0544] mstockstill on PROD1PC66 with NOTICES Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information 16:33 Mar 21, 2008 Average burden per response (in hours) 27 1 1.5 41 27 1 1.5 41 300 27 1 1 20/60 1.5 100 41 18 1 ........................ ........................ In-depth Interview Guide for Community Hematologists and Oncologists. In-depth Interview Guide for Patients. Primary Care Provider Survey ........ Interview Guide for Primary Care Providers. Focus Group Guide for Primary Care Providers. Dated: March 18, 2008. Marilyn S. Radke, Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E8–5859 Filed 3–21–08; 8:45 am] VerDate Aug<31>2005 Number of responses per respondent Number of respondents Form name Jkt 214001 on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project NIOSH Customer Satisfaction Survey—Reinstatement—National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. Background and brief description: The mission of the National Institute for Occupational Safety and Health (NIOSH) is to promote safety and health at work for all people through research and prevention. The Occupational Safety and Health Act, Public Law 91– 596 (section 20[a] [1]) authorizes the National Institute for Occupational Safety and Health (NIOSH) to conduct research to advance the health and safety of workers. NIOSH conducted a baseline survey in 2003 to assess customer satisfaction with NIOSH communication products, services, and methods of dissemination [OMB no. 0920–0544 expired 03/31/2003]. The baseline survey established an initial benchmark for gauging the effectiveness of NIOSH’s communication products, outreach services, and identified areas for improvement. NIOSH is conducting a follow-up Customer Satisfaction Survey of occupational safety and health professionals. A mail survey is planned with an option that will allow respondents to complete the survey electronically. The current survey is a 5year follow-up designed to enable NIOSH to determine the current level of customer satisfaction and identify changes that have occurred in the intervening years. The purpose of this survey is to evaluate the effectiveness of PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 2 .......................... Total burden (in hours) 36 259 NIOSH’s communication and dissemination program as a whole in serving the broad occupational safety and health professional community by addressing five questions: (1) To what extent are NIOSH communication products viewed as credible, useful sources of information on occupational safety and health issues? (2) To what extent has NIOSH been successful in distributing its communication products to its primary and traditional audience? (3) To what extent, and in what ways, have NIOSH communication products influenced workplace safety and health program policies and practices, or resolved other related issues? (4) What improvements could be made in the nature of NIOSH communication products and/or their manner of delivery that could enhance their use and benefits? (5) What is the reach and perceived importance of NIOSH outreach initiatives? The survey will be directed to the community of occupational safety and health professionals, as this audience represents the primary and traditional customer base for NIOSH information materials. For this purpose four major associations identified with occupational safety and health matters have indicated their willingness to partner with NIOSH on this follow-up survey, as they did on the baseline. These are the American Industrial Hygiene Association (AIHA), the American College of Occupational and Environmental Medicine (ACOEM), the American Association of Occupational Health Nurses (AAOHN), and the American Society of Safety Engineers (ASSE). There is no cost to respondents other than their time. Estimated Annualized Burden Hours: E:\FR\FM\24MRN1.SGM 24MRN1

Agencies

[Federal Register Volume 73, Number 57 (Monday, March 24, 2008)]
[Notices]
[Pages 15524-15525]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-5859]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-08-08AU]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 
and send comments to Maryam Daneshvar, CDC Acting Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to omb@cdc.gov.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Assessing Problem Areas in Referrals for Chronic Hematologic 
Malignancies and Developing Interventions to Address Them--New--
Division of Cancer Prevention and Control (DCPC), National Center for 
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for 
Disease Control and Prevention (CDC).
    Background and Brief Description: One of the six aims of the 
Insitute of Medicine's Crossing the Quality Chasm report is to improve 
the timeliness of care for patients. Data from Europe and Canada, as 
well as single-site studies in the United States, allude to a problem 
of timely referral and diagnosis for patients with cancer. Despite the 
advent of new diagnostics and therapeutics for patients with chronic 
hematological malignancies, the size and scope of a potential problem 
regarding their referral from primary care providers to specialists is 
not well-defined in the current literature.
    CDC proposes to conduct a one-time study to collect qualitative and 
quantitative information on optimal and sub-optimal referral patterns 
for patients with confirmed or suspected chronic hematologic 
malignancies. Information will be collected to identify specific 
factors related to delays in diagnosis and/or referral to appropriate 
medical specialists. Information will be collected through in-depth 
interviews with hematologic cancer patients, in-depth interviews and 
focus groups with primary care providers, interviews with specialists 
in hematology and oncology in Texas, and a one-time postal survey to a 
sample of primary care providers (physicians and advance practice 
nurses) in Massachusetts.
    The ultimate goal is to develop tools that will improve the 
awareness, diagnosis, and referral of persons with chronic 
hematological cancers by primary care providers.
    There are no costs to respondents other than their time.

[[Page 15525]]



                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                            Number of     Average burden
              Type of respondents                               Form name                   Number of     responses per    per response    Total burden
                                                                                           respondents     respondent       (in hours)      (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Community Oncologists/Hematologists............  In-depth Interview Guide for Community              27               1              1.5              41
                                                  Hematologists and Oncologists.
Patients.......................................  In-depth Interview Guide for Patients.              27               1              1.5              41
Primary Care Providers.........................  Primary Care Provider Survey..........             300               1          20/60               100
                                                 Interview Guide for Primary Care                    27               1              1.5              41
                                                  Providers.
                                                 Focus Group Guide for Primary Care                  18               1              2                36
                                                  Providers.
                                                                                        ----------------------------------------------------------------
    Total......................................  ......................................  ..............  ..............  ...............             259
--------------------------------------------------------------------------------------------------------------------------------------------------------


    Dated: March 18, 2008.
Marilyn S. Radke,
Reports Clearance Officer, Centers for Disease Control and Prevention.
 [FR Doc. E8-5859 Filed 3-21-08; 8:45 am]
BILLING CODE 4163-18-P